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Clinical PerspectiveWhat Is New?We have demonstrated that our multimodal platform, which combines laser speckle imaging, arterial blood pressure (BP), and electroencephalography, can monitor and quantify BP pulsatility and cerebral blood flow pulsatility in regard to short‐term neuroelectrical recovery after cardiac arrest and resuscitation.Alterations in cerebral blood flow pulsatility occur during the short‐term (\<2 hours) postresuscitation period, yet surprisingly may not be associated with short‐term neuroelectrical recovery.Although BP pulsatility changes little from baseline, higher BP pulsatility after resuscitation may be associated with worse short‐term neuroelectrical recovery.What Are the Clinical Implications?Our data suggest that monitoring BP pulsatility (eg, pulse pressure) and related waveform analyses of BP within 2 hours of cardiac arrest and resuscitation may be important to help inform the neurological recovery of patients.A combined effort to monitor and modify mean arterial pressure and pulse pressure could lead to more specific BP guidelines and the development of therapeutic interventions that possibly target pulsatile features of BP.

Introduction {#jah34707-sec-0008}
============

Annually, \>550 000 people in the United States experience cardiac arrest (CA), and initial survival rates remain poor (10%--30%).[1](#jah34707-bib-0001){ref-type="ref"} Approximately 85% to 90% of survivors have impaired cognitive function, which leads to decreased quality of life for survivors, increased burden on caregivers, and direct costs of \>\$6 billion/year.[1](#jah34707-bib-0001){ref-type="ref"}, [2](#jah34707-bib-0002){ref-type="ref"} To improve neurological recovery and understand how the brain recovers after CA, a critical need exists to characterize physiological processes that impact the brain, such as cerebral blood flow (CBF), arterial blood pressure (ABP), and brain electrophysiology.

A key physiological process that has been shown to be extremely important is pulsatile blood flow because of its impact on oxygen uptake, vascular tone, and cellular metabolism.[3](#jah34707-bib-0003){ref-type="ref"} Studies have shown that pulsatile flow (compared with nonpulsatile flow) during cardiac bypass surgery and extracorporeal membrane life support is associated with improved neurological and physiological outcomes.[4](#jah34707-bib-0004){ref-type="ref"}, [5](#jah34707-bib-0005){ref-type="ref"}, [6](#jah34707-bib-0006){ref-type="ref"}, [7](#jah34707-bib-0007){ref-type="ref"} Furthermore, the use of mechanically controlled devices to induce pulsatile blood flow is associated with reduced cerebrovascular resistance (CVR) and improved oxygen uptake during postischemic reperfusion, which can improve neurological outcome.[8](#jah34707-bib-0008){ref-type="ref"} These studies show that in the binary case of pulsatile versus nonpulsatile flow, significant neurological benefits occur with pulsatile flow.[4](#jah34707-bib-0004){ref-type="ref"}, [5](#jah34707-bib-0005){ref-type="ref"}, [6](#jah34707-bib-0006){ref-type="ref"}, [7](#jah34707-bib-0007){ref-type="ref"}, [8](#jah34707-bib-0008){ref-type="ref"} However, aging,[9](#jah34707-bib-0009){ref-type="ref"}, [10](#jah34707-bib-0010){ref-type="ref"}, [11](#jah34707-bib-0011){ref-type="ref"} stroke,[12](#jah34707-bib-0012){ref-type="ref"} acute brain injury,[13](#jah34707-bib-0013){ref-type="ref"} small‐vessel disease,[14](#jah34707-bib-0014){ref-type="ref"} and CA[15](#jah34707-bib-0015){ref-type="ref"}, [16](#jah34707-bib-0016){ref-type="ref"} all modulate pulsatile blood flow to different degrees. Results from these studies suggest conflicting associations between whether increased or decreased pulsatility results in better neurological outcome.

To better understand the relationship between pulsatility and neurological outcome after CA, several gaps in the knowledge base must be addressed. First, low‐frequency (\<0.4‐Hz) pulsatile studies have typically examined survivors versus nonsurvivors of CA, with little analysis of neurological function or outcome after CA.[17](#jah34707-bib-0017){ref-type="ref"} Second, studies of the pulsatile waveform attributable to each heartbeat typically focus on CBF of the middle cerebral artery[15](#jah34707-bib-0015){ref-type="ref"} and not cerebral microvasculature or peripheral hemodynamics (eg, aorta or femoral artery). Third, the influence of CVR on CBF and its association with the peripheral pulsatile waveform has not been investigated. Finally, clinical studies begin on hospital admission, followed by measurements on subsequent days after CA, and hence do not enable study of immediate pulsatile signal changes after resuscitation (during ischemia‐induced hyperemia and hypoperfusion) and their relationship to neurological outcome.

To address these gaps, we used an established, translational preclinical model of asphyxial CA (ACA) that mimics the hospital setting.[18](#jah34707-bib-0018){ref-type="ref"}, [19](#jah34707-bib-0019){ref-type="ref"}, [20](#jah34707-bib-0020){ref-type="ref"} Using our novel preclinical platform, we continuously monitored and quantified pulsatile femoral ABP and, for the first time, pulsatile CBF of the cerebral microvasculature using high‐speed optical imaging during CA and resuscitation. We hypothesized that higher CBF pulsatility would be associated with improved short‐term neuroelectrical recovery. However, we show that higher ABP pulsatility is associated with worse short‐term neuroelectrical recovery, whereas CBF pulsatility is not associated with short‐term neuroelectrical recovery.

Materials and Methods {#jah34707-sec-0009}
=====================

The data that support the findings of this study are available from the corresponding author on reasonable request. The ACA model and study protocol (No. 2013‐3098) were approved by the Institutional Animal Care and Use Committee at the University of California, Irvine. Additional methods and results can be found in Data [S1](#jah34707-sup-0001){ref-type="supplementary-material"}.

Animal Preparation {#jah34707-sec-0010}
------------------

We used our ACA model[18](#jah34707-bib-0018){ref-type="ref"}, [19](#jah34707-bib-0019){ref-type="ref"}, [20](#jah34707-bib-0020){ref-type="ref"}, [21](#jah34707-bib-0021){ref-type="ref"}, [22](#jah34707-bib-0022){ref-type="ref"} to perform experiments on 11 adult male Wistar rats (Charles River). Baseline characteristics are shown in Table [1](#jah34707-tbl-0001){ref-type="table"}. Rats were calorically restricted 12 to 16 hours before onset of ACA. On the day of ACA induction, rats were anesthetized, intubated, and connected to a mechanical ventilator via tubing (Kent Scientific, Torrington, CT). During surgery, isoflurane was maintained at 2% with a 50/50 N~2~/O~2~ mixture at 2 LPM (liters per minute). The ventilation settings were maintained at 70 beats per minute, with 12 to 14 cm H~2~O peak inspiration pressure and 3 cm H~2~O peak end expiratory pressure. Animal temperature was continuously measured with a rectal thermometer (Kent Scientific) and maintained between 36.5°C and 37.5°C.

###### 

Baseline Characteristics of Study Subjects

  Characteristics                5‐min ACA (n=6)        7‐min ACA (n=5)        *P* Value
  ------------------------------ ---------------------- ---------------------- -----------
  Preparation time, h            6.28 (5.29--6.64)      5.23 (5.13--5.27)      0.537
  Weight, g                      333 (328--378)         355 (341--374)         0.937
  Temperature, °C                37.0 (36.7--37.3)      37.0 (37.0--37.2)      0.944
  pH                             7.40 (7.40--7.40)      7.43 (7.42--7.45)      0.346
  [pco]{.smallcaps} ~2~, mm Hg   39.7 (37.2--41.4)      34.8 (34.0--39.2)      0.247
  [po]{.smallcaps} ~2~, mm Hg    159.5 (144.0--175.0)   139.0 (128.0--141.0)   0.247
  $\text{HCO}_{3}^{-}$, mmol/L   25.4 (24.5--25.7)      25.4 (23.1--25.6)      0.662
  Hemoglobin, g/dL               12.6 (11.2--13.4)      12.2 (10.9--12.9)      0.771

Data are presented as median (interquartile range). The *P* value was calculated with a 2‐sided Wilcoxon ranked sum test. ACA indicates asphyxial cardiac arrest.

The intubated rat was positioned on a stereotactic frame (Kopf Instruments, Tujunga, CA). A midline incision was performed over the scalp, and the scalp was retracted to expose the skull for electroencephalographic (EEG) electrode implantation (Plastics One Inc, Roanoke, VA). Two frontal electrodes were implanted 2 mm anterior and 2.5 mm lateral to bregma, and a third electrode was implanted over the visual cortex 5.5 mm posterior and 4 mm left of bregma. A reference electrode was implanted 3 mm posterior to lambda. After electrode implantation, a 4×6‐mm craniectomy was created over the right sensory and visual cortices to create a window for optical imaging. Saline was applied periodically to ensure the brain remained hydrated. After the craniectomy, the femoral artery and vein were cannulated. Invasive ABP from the femoral artery was measured continuously at ≈200 Hz. Baseline arterial blood gas measurements (Abaxis, Union City, CA) were obtained within 30 minutes before initiation of ACA.

Experimental Protocol {#jah34707-sec-0011}
---------------------

At experiment start time, rats were placed on 0.5% to 1.0% isoflurane (balance, 100% O~2~). After 2 minutes, inhaled air was changed to room air (21% O~2~), isoflurane administration was turned off to wash out anesthesia, and neuromuscular blockade was initiated with 1 mL of IV vecuronium (2 mg/kg), flushed with 1 mL of heparinized saline. At 5 minutes, asphyxia was initiated by turning the ventilator off and clamping the tubing. Rats were subjected to a period of either 5‐ or 7‐minute asphyxia to mimic mild or moderate severity of CA, respectively. Thirty seconds before the end of the asphyxial period, mechanical ventilation was reinitiated at 100% O~2~ with respiratory rate of 75 to 85 beats per minute, peak inspiration pressure of 17.5 to 18.5 cm H~2~O, and peak end expiratory pressure of 3 cm H~2~O at 2.5 LPM. Epinephrine (0.01 mg/kg) and sodium bicarbonate (1 mmol/kg), followed by 2 mL of heparinized saline, were administered intravenously. Chest compressions were started at the end of the asphyxial period until return of spontaneous circulation (ROSC) was achieved. Arterial blood gases were obtained 10 minutes after ROSC and every 40 minutes thereafter, to assess and modify ventilator settings as necessary.

Data Acquisition {#jah34707-sec-0012}
----------------

As previously described in detail,[18](#jah34707-bib-0018){ref-type="ref"} we used a multimodal approach that combined laser speckle imaging (LSI), ABP, and electroencephalography to monitor CBF, femoral ABP, and brain electrophysiology before, during, and after ACA and resuscitation. Briefly, LSI data were obtained using an 809‐nm laser (Ondax Inc, Monrovia, CA) as the excitation source, and images were acquired at ≈60 fps (frames per second) using a Point Grey camera with a 10‐ms exposure time. To measure ABP, systolic and diastolic blood pressures were recorded from the femoral artery at ≈200 Hz. The mean arterial pressure (MAP) was calculated at 1 Hz from the extracted systolic and diastolic blood pressure waveforms. EEG data acquisition was recorded from each implanted electrode at 1526 Hz with a first‐order high‐pass filter (0.35 Hz). EEG and ABP data were collected via a Tucker Davis Technologies (Alachua, FL) RZ5D platform and digitally time synchronized. The LSI data were manually synchronized to EEG and ABP data using the experiment start time (time=0 minutes).

Initial Data Processing {#jah34707-sec-0013}
-----------------------

LSI processing used custom‐written MATLAB (The Mathworks Inc, Natick, MA) code to process each raw speckle image and obtain CBF data. A 5×5 sliding window was used to convert each raw speckle image to a corresponding speckle contrast (K) image using the equation K=σ/\<I\>, where σ is the SD of the intensity and \<I\> is the average intensity within each sliding window position. Each speckle contrast image was then converted to a CBF map using a simplified speckle imaging equation CBF=1/2TK^2^, where T is the exposure time of the camera in seconds.[23](#jah34707-bib-0023){ref-type="ref"} A representative region of interest was then selected within the craniectomy to obtain an average CBF value and create time‐resolved pulsatile CBF waveforms. To create pulsatile relative CBF (rCBF) time courses, we normalized the CBF at each time point to the baseline CBF. The baseline CBF was defined as the mean CBF calculated over a 1‐minute interval immediately before the onset of asphyxia.

Raw EEG data were filtered using custom‐written MATLAB code. Data were detrended, and common average referencing was performed using each electrode.[24](#jah34707-bib-0024){ref-type="ref"} A finite impulse response notch filter at 60 Hz was used, followed by a finite impulse response bandpass filter from 1 to 150 Hz. Signals were then downsampled to 600 Hz to reduce computational time.

Pulsatile Signal Analysis {#jah34707-sec-0014}
-------------------------

To quantify CBF and ABP pulsatile waveform changes in response to ACA, 2 previously published methods were used. The first method used the maximum value of the power spectrum (peak power), and the second calculated the difference between the peak and trough values (peak to trough) of the pulsatile waveform signal[25](#jah34707-bib-0025){ref-type="ref"}, [26](#jah34707-bib-0026){ref-type="ref"}, [27](#jah34707-bib-0027){ref-type="ref"} (shown in Figure [1](#jah34707-fig-0001){ref-type="fig"}B). CBF and ABP data from each experiment were analyzed. Time periods during signal artifact caused by bleeding, movement, and noise, arterial blood gas measurements, and the absence of pulsatile data during the later periods of CA were manually removed from further analysis.

![Pulsatile cerebral blood flow (CBF) and arterial blood pressure (ABP) dynamics after resuscitation from asphyxial cardiac arrest (ACA). **A**, Relative CBF (rCBF) (green; **top**) and ABP (purple; **bottom**) time courses during a representative ACA and resuscitation experiment. **B** through **F**, Representative 1.5‐second periods of rCBF data from phases labeled in **A** (**top**). The *y* axis is rescaled for each figure (**B** through **F**) to show the same CBF range. **B**, Baseline pulsatile CBF. **C**, Cardiac arrest (CA) pulsatile CBF. **D**, Hyperemia pulsatile CBF. **E**, Early hypoperfusion pulsatile CBF. **F**, Late hypoperfusion pulsatile CBF. **G** through **K**, Representative 1.5 seconds of ABP data from phases labeled in **A** (**bottom**). The *y* axis is rescaled for each figure (**G** through **K**) to show the same blood pressure range. **G**, Baseline pulsatile ABP. **H**,CA pulsatile ABP. **I**, Hyperemia pulsatile ABP. **J**, Early hypoperfusion phase of pulsatile ABP. **K**, Late hypoperfusion phase of pulsatile ABP. CPR indicates cardiopulmonary resuscitation.](JAH3-9-e012691-g001){#jah34707-fig-0001}

To use the peak power from the power spectrum, an accurate measurement of heart rate is needed. Previous articles have used LSI to quantify the heart rate and pulsatile blood flow waveform flow from the skin[26](#jah34707-bib-0026){ref-type="ref"}, [27](#jah34707-bib-0027){ref-type="ref"}, [28](#jah34707-bib-0028){ref-type="ref"} and teeth.[29](#jah34707-bib-0029){ref-type="ref"} However, to the best of our knowledge, LSI has never been used to obtain and quantify pulsatile CBF data during CA and resuscitation. To ensure accurate CBF peak power quantification from the power spectrum, the CBF heart rate was compared with the ABP heart rate as the gold standard. See [Results](#jah34707-sec-0005){ref-type="sec"} (Figure [2](#jah34707-fig-0002){ref-type="fig"}) for comparison.

![Heart rate calculations from cerebral blood flow (CBF) data agree well with those from arterial blood pressure (ABP) data during all experimental phases. **A**, Time courses from each of the 11 subjects that compare ABP and CBF heart rate (HR) calculations. Data from laser speckle imaging to measure CBF are in green, and data from peripheral ABP are in purple. **B**, Comparison of ABP and CBF HR calculations from all experiments (n=11) during asphyxial (n=358; *R* ^2^=0.80; **left**), nonasphyxial (n=4615; *R* ^2^=0.93; **middle**), and all experimental time points (n=4973; *R* ^2^=0.94; **right**).](JAH3-9-e012691-g002){#jah34707-fig-0002}

To obtain the heart rate and extract the peak power from the power spectrum, the following steps were performed for both the pulsatile CBF and ABP time courses. First, a bandpass filter from 0.5 to 10 Hz was used to remove the DC component and low‐ and high‐frequency content. Next, the time‐resolved power spectrum was computed using 10‐second intervals with 2 seconds of overlap. During nonasphyxial periods, the maximum power in the 4‐ to 9‐Hz (240--540 beats/minute, typical rat heart rate values) frequency band was extracted within each interval. During the asphyxial period, the maximum power from all frequencies was extracted within each interval. Time courses of peak power were then normalized to the baseline peak power, which is defined as the mean peak power during a 1‐minute period immediately preceding the onset of asphyxia. The heart rate was computed by extracting the frequency that corresponded to the peak power. The heart rate calculated from the CBF data was compared with the heart rate calculated from the ABP data.

To calculate the peak‐to‐trough time courses from the pulsatile CBF and ABP signals, the following steps were performed. First, a bandpass filter from 0.5 to 10 Hz was used. Next, local peaks and troughs were determined over 1‐second intervals using the pulsatile signals for the entire time course. A 10‐second sliding average filter was applied to the peak and trough time courses separately. The difference between the filtered peak and trough time courses was calculated to obtain the peak‐to‐trough data. Time courses of peak to trough were then normalized to the baseline peak to trough, which is defined as the mean peak to trough during a 1‐minute period immediately preceding the onset of asphyxia to minimize effects caused by isoflurane.

Cerebrovascular Resistance {#jah34707-sec-0015}
--------------------------

Relative CVR versus time \[rCVR(t)\] is defined as rCVR(t)=rMAP(t)/rCBF(t),[30](#jah34707-bib-0030){ref-type="ref"} where rMAP is the MAP normalized by the baseline MAP, which is defined as the mean MAP calculated over a 1‐minute interval immediately before onset of asphyxia. rCBF was calculated as follows. A 10‐second sliding median filter was applied to the pulsatile CBF time courses to remove the pulsatile component. The filtered waveform was then normalized to the mean median‐filtered CBF calculated over a 1‐minute interval immediately before onset of asphyxia. The rCBF data were then downsampled to 1 Hz to match the rMAP data, and the rCVR was calculated as the quotient of the 2 waveforms.

Electroencephalographic Information Quantity {#jah34707-sec-0016}
--------------------------------------------

To obtain a measurement of short‐term neuroelectrical recovery, we used a qEEG (quantitative EEG) method called information quantity (IQ).[31](#jah34707-bib-0031){ref-type="ref"}, [32](#jah34707-bib-0032){ref-type="ref"} The following steps were performed to obtain EEG IQ as a function of time. Using a temporal sliding window of 10 seconds with 20% overlap, a 5‐level discrete wavelet transform was applied to the filtered EEG data to extract discrete wavelet transform coefficients. One minute before the onset of asphyxia, 20 fixed microstates were calculated that encompassed the mean±3 SDs of the discrete wavelet transform coefficients. A histogram of the continuous EEG recording was created using the discrete wavelet transform coefficients with 20 microstates. The probability distribution function was calculated, from the histogram, and the Shannon entropy (SE) was calculated using the equation ${SE} = - \sum{}_{m = 1}^{M}{pdf}{(m)}{lo}g_{2}{({{pdf}(m)})}$. M is the number of microstates, and pdf is the probability distribution function from the histogram. We used this equation within each 10‐second window to calculate EEG IQ as a function of time. The EEG IQ was then normalized to the baseline EEG IQ, which is defined as the mean EEG IQ calculated over a 1‐minute interval immediately before onset of asphyxia. An EEG IQ of 0 indicates no brain electrical activity, whereas an EEG IQ of 1 indicates normal brain electrical activity.

Extracted Parameters and Statistical Analysis {#jah34707-sec-0017}
---------------------------------------------

To assess changes in CBF and ABP pulsatility, the peak power and peak‐to‐trough data were extracted over 1‐minute intervals during baseline, CA, hyperemia (≈10 minutes after ROSC), early hypoperfusion (≈20 minutes after ROSC), and late hypoperfusion (≈60 minutes after ROSC). These periods are labeled in Figure [1](#jah34707-fig-0001){ref-type="fig"} as B through F and G through K for the CBF and ABP data, respectively. Similarly, rCVR was extracted during the same time intervals. To determine the effects of asphyxial duration on peak power, peak to trough, and rCVR, a 2‐sided Wilcoxon ranked sum test was used to compare 5‐ and 7‐minute ACA at baseline, CA, hyperemia, early hypoperfusion, and late hypoperfusion. To determine the response of peak power, peak to trough, and rCVR after ACA, a 2‐sided, paired Wilcoxon signed rank test was used to compare baseline levels with subsequent experimental time periods. To determine the association between pulsatility and rCVR, a Spearman ranked correlation was used.

To obtain a metric of short‐term neuroelectrical recovery, a surrogate for neurological outcome, the median EEG IQ from 90 to 100 minutes after ROSC was determined. To assess the relationship between CBF and ABP pulsatility to short‐term neuroelectrical recovery, a Spearman ranked correlation was used.

Results {#jah34707-sec-0018}
=======

Arterial blood gas measurements taken 10, 50, and 90 minutes after ROSC are shown in Table [2](#jah34707-tbl-0002){ref-type="table"}. There is no significant difference between 5‐ and 7‐minute ACA for pH, [pco]{.smallcaps} ~2~, [po]{.smallcaps} ~2~, $\text{HCO}_{3}^{-}$, and hemoglobin at all time points (*P*\>0.05).

###### 

Arterial Blood Gas Characteristics After ROSC

  Characteristics                5‐min ACA (n=6)        7‐min ACA (n=5)        *P* Value
  ------------------------------ ---------------------- ---------------------- -----------
  10 min after ROSC                                                            
  pH                             7.28 (7.25--7.29)      7.29 (7.27--7.30)      0.537
  [pco]{.smallcaps} ~2~, mm Hg   50.4 (49.4--58.2)      38.0 (36.7--44.7)      0.177
  [po]{.smallcaps} ~2~, mm Hg    136.0 (83.5--221.5)    237.0 (146.0--250.0)   0.537
  $\text{HCO}_{3}^{-}$, mmol/L   23.3 (22.3--25.6)      18.4 (18.0--20.5)      0.082
  Hemoglobin, g/dL               10.5 (9.0--12.3)       10.9 (10.5--11.6)      0.792
  50 min after ROSC                                                            
  pH                             7.32 (7.26--7.36)      7.42 (7.37--7.43)      0.329
  [pco]{.smallcaps} ~2~, mm Hg   51.6 (44.8--66.2)      38.6 (33.3--39.3)      0.177
  [po]{.smallcaps} ~2~, mm Hg    282.5 (137.3--360.3)   382.0 (341.0--385.0)   0.329
  $\text{HCO}_{3}^{-}$, mmol/L   27.1 (25.7--31.0)      23.0 (22.5--26.0)      0.195
  Hemoglobin, g/dL               11.8 (10.8--12.7)      10.9 (10.9--11.2)      0.758
  90 min after ROSC                                                            
  pH                             7.44 (7.39--7.48)      7.23 (7.18--7.27)      0.052
  [pco]{.smallcaps} ~2~, mm Hg   39.0 (33.8--46.0)      60.3 (59.8--64.6)      0.177
  [po]{.smallcaps} ~2~, mm Hg    324.0 (190.0--458.8)   133.0 (117.0--319.0)   0.126
  $\text{HCO}_{3}^{-}$, mmol/L   28.8 (24.4--29.4)      25.1 (24.8--25.8)      0.537
  Hemoglobin, g/dL               10.9 (9.3--11.7)       11.2 (10.2--11.9)      0.740

Data are presented as median (interquartile range). The *P* value was calculated with a 2‐sided Wilcoxon ranked sum test. ACA indicates asphyxial cardiac arrest; ROSC, return of spontaneous circulation.

After Resuscitation From ACA, CBF and Femoral Artery Pulsatility Characteristics Vary Considerably {#jah34707-sec-0019}
--------------------------------------------------------------------------------------------------

Figure [1](#jah34707-fig-0001){ref-type="fig"}A shows representative time courses of CBF (top) and ABP (bottom) after an ACA and resuscitation experiment. ABP decreases and CBF increases during the baseline period (0--5 minutes). We speculate that the administration of vecuronium causes relaxation of muscles (ie, intercostal and limb muscles) that can lead to peripheral pooling of blood that results in a decrease in ABP, whereas arousal and brain activation from washout of isoflurane in our paradigm may cause an increase in rCBF, despite isoflurane being known to increase CBF. Figure [1](#jah34707-fig-0001){ref-type="fig"}B through [1](#jah34707-fig-0001){ref-type="fig"}F shows representative 1.5‐second periods of CBF data during specific phases labeled in Figure [1](#jah34707-fig-0001){ref-type="fig"}A (top). The *y* axis of Figure [1](#jah34707-fig-0001){ref-type="fig"}B through [1](#jah34707-fig-0001){ref-type="fig"}F is rescaled to keep the same CBF range in each subfigure. Figure [1](#jah34707-fig-0001){ref-type="fig"}B shows baseline pulsatile CBF waveform with an example of the peak and trough labeled. Figure [1](#jah34707-fig-0001){ref-type="fig"}C shows CBF pulsatility during CA with low amplitude and overall low flow. Figure [1](#jah34707-fig-0001){ref-type="fig"}D shows CBF pulsatility during hyperemia. Compared with baseline, the CBF waveform in this phase is higher in amplitude and consists of sharper features. Figure [1](#jah34707-fig-0001){ref-type="fig"}E shows CBF pulsatility during early hypoperfusion. The CBF pulsatility has a lower amplitude than during both hyperemia and baseline, with overall lower flow. Figure [1](#jah34707-fig-0001){ref-type="fig"}F shows CBF pulsatility during late hypoperfusion. The CBF pulsatility has a lower amplitude than during both hyperemia and baseline, with overall lower flow. During baseline, hyperemia, and early hypoperfusion, respiratory variations are observed as a low‐frequency oscillation in the CBF data that is not observed during CA and is difficult to visualize during late hypoperfusion.

Figure [1](#jah34707-fig-0001){ref-type="fig"}G through [1](#jah34707-fig-0001){ref-type="fig"}K shows representative 1.5‐second periods of ABP data during the same phases labeled in Figure [1](#jah34707-fig-0001){ref-type="fig"}A (bottom). The *y* axis of Figure [1](#jah34707-fig-0001){ref-type="fig"}G through [1](#jah34707-fig-0001){ref-type="fig"}K is rescaled to keep the same blood pressure range in each subfigure. Figure [1](#jah34707-fig-0001){ref-type="fig"}G shows the pulsatile ABP waveform during baseline. Figure [1](#jah34707-fig-0001){ref-type="fig"}H shows the pulsatile ABP during CA, with a nearly featureless waveform. Figure [1](#jah34707-fig-0001){ref-type="fig"}I shows ABP pulsatility during hyperemia, with a return in pulsatility and a slightly higher amplitude than during baseline. Figure [1](#jah34707-fig-0001){ref-type="fig"}J shows ABP pulsatility during early hypoperfusion. Unlike the decreased CBF pulsatility during early hypoperfusion, the ABP pulsatility is near baseline levels. Figure [1](#jah34707-fig-0001){ref-type="fig"}K shows ABP pulsatility during late hypoperfusion, with similar pulsatility to early hypoperfusion. During baseline, hyperemia, early hypoperfusion, and late hypoperfusion, respiratory variations are observed as a slow frequency oscillation in the ABP data that is not observed during CA.

LSI Enables Accurate Quantification of Heart Rate Measured From the Rodent Brain {#jah34707-sec-0020}
--------------------------------------------------------------------------------

To determine if LSI is able to quantitatively resolve CBF heart rate changes, heart rate calculations measured from LSI data were compared with the ABP heart rate calculations as the gold standard. Figure [2](#jah34707-fig-0002){ref-type="fig"}A shows time courses of heart rate calculations measured from each experiment using CBF data (green) and ABP data (purple). The data collectively show excellent agreement across all experiments (n=11). Figure [2](#jah34707-fig-0002){ref-type="fig"}B quantifies the linear correlation between the heart rate calculated using all CBF and ABP data. The linear correlation was examined in 3 periods: (1) only asphyxial time points (left), (2) only nonasphyxial time points (middle), and (3) combined asphyxial and nonasphyxial time points (right). Using only asphyxial time points (n=358), the *R* ^2^=0.80; using only nonasphyxial time points (n=4615), the *R* ^2^=0.93; and using all experimental time points (n=4973), the *R* ^2^=0.94.

CBF Pulsatility Dynamically Changes From Baseline, Whereas ABP Pulsatility Remains Fairly Stable {#jah34707-sec-0021}
------------------------------------------------------------------------------------------------

After pooling the 5‐ and 7‐minute ACA, there was no significant difference between CBF and ABP pulsatility during hyperemia (peak to trough: *P*=0.15; peak power: *P*=0.12), but there were significant deficits in CBF pulsatility during early hypoperfusion (peak to trough: *P*=0.003; peak power: *P*\<0.001) and late hypoperfusion (peak to trough: *P*\<0.001; peak power: *P*\<0.001) in comparison to ABP pulsatility metrics (n=11) (Figure [3](#jah34707-fig-0003){ref-type="fig"}).

![Resuscitation after asphyxial cardiac arrest (ACA) leads to deficits in cerebral blood flow (CBF) pulsatility, whereas arterial blood pressure (ABP) pulsatility minimally changes. Combined 5‐ and 7‐minute ACA comparison between CBF (green, circle) pulsatility and ABP (purple, square) pulsatility (n=11) using normalized peak‐to‐trough metric (**A**) and normalized peak power metric (**B**). Experimental phases are baseline (B), cardiac arrest (CA), hyperemia (H), early hypoperfusion (EH), and late hypoperfusion (LH). \**P*\<0.05, \*\**P*\<0.01, and \*\*\**P*\<0.001.](JAH3-9-e012691-g003){#jah34707-fig-0003}

We then compared baseline CBF and ABP pulsatility metrics with their respective metrics during CA, hyperemia, early hypoperfusion, and late hypoperfusion (n=11). CBF pulsatility during CA was significantly less than baseline CBF pulsatility (peak to trough: *P*\<0.001; peak power: *P*\<0.001). On the other hand, CBF pulsatility during hyperemia was significantly higher than CBF pulsatility at baseline (peak to trough: *P*=0.02; peak power: *P*=0.03). However, CBF pulsatility during early hypoperfusion (peak to trough: *P*=0.003; peak power: *P*\<0.001) and late hypoperfusion (peak to trough: *P*\<0.001; peak power: *P*\<0.001) had significant deficits in comparison to baseline CBF pulsatility.

Meanwhile, CA ABP pulsatility was significantly less than baseline ABP pulsatility (peak to trough: *P*\<0.001; peak power: *P*\<0.001). ABP pulsatility only showed deficits in peak power (not peak to trough) during early hypoperfusion (peak power: *P*=0.01) compared with baseline ABP pulsatility. During hyperemia and late hypoperfusion, ABP pulsatility was not significantly different from baseline ABP pulsatility (n=11).

We also tested if CBF pulsatility (normalized peak to trough) followed overall CBF changes, during hyperemia, early hypoperfusion, and late hypoperfusion (n=11). There was a strong significant positive correlation during hyperemia (*R*=0.86; *P*=0.001). However, there was no significant correlation during early (*R*=0.32; *P*=0.34) and late hypoperfusion (*R*=0.37; *P*=0.26) (Figure [S1](#jah34707-sup-0001){ref-type="supplementary-material"}).

Longer Asphyxial Duration Leads to Higher ABP Pulsatility Only During the Late Hypoperfusion Phase, But Does Not Significantly Influence Deficits in CBF Pulsatility {#jah34707-sec-0022}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------

To assess the effects of asphyxial duration on CBF and ABP pulsatility, 5‐minute (n=6) and 7‐minute (n=5) ACA values were compared during CA, hyperemia, early hypoperfusion, and late hypoperfusion. There were no significant differences between either the normalized peak power and peak‐to‐trough CBF pulsatility metrics for 5‐ and 7‐minute ACA experiments during each experiment phase (*P*\>0.05) (Figure [4](#jah34707-fig-0004){ref-type="fig"}A and [4](#jah34707-fig-0004){ref-type="fig"}B). However, during hyperemia, there was a nonsignificant trend toward increased CBF pulsatility for 7‐minute ACA experiments. There was no significant difference between either the normalized peak power and peak‐to‐trough ABP pulsatility metrics for 5‐ and 7‐minute ACA experiments during CA, hyperemia, and early hypoperfusion (*P*\>0.05) (Figure [4](#jah34707-fig-0004){ref-type="fig"}C and [4](#jah34707-fig-0004){ref-type="fig"}D). Similar to CBF pulsatility, during hyperemia, there was a nonsignificant trend toward increased ABP pulsatility for 7‐minute ACA experiments. However, during late hypoperfusion, 7‐minute ACA experiments had significantly more ABP pulsatility than 5‐minute ACA experiments, using both the normalized peak power (*P*=0.03) and normalized peak‐to‐trough (*P*=0.03) pulsatility metrics (Figure [4](#jah34707-fig-0004){ref-type="fig"}C and [4](#jah34707-fig-0004){ref-type="fig"}D).

![Longer asphyxial duration leads to higher arterial blood pressure (ABP) pulsatility, but does not significantly influence deficits in cerebral blood flow (CBF) pulsatility. **A** and **B**, Two methods to calculate CBF pulsatility (normalized peak to trough and peak power) demonstrate that there is no significant difference in CBF pulsatility between 5‐minute (n=6) and 7‐minute (n=5) asphyxial cardiac arrest (ACA) experiments during cardiac arrest (CA), hyperemia (H), early hypoperfusion (EH), and late hypoperfusion (LH). **C** and **D**, Two methods to calculate ABP pulsatility (normalized peak to trough and peak power) demonstrate that there is no significant difference between 5‐minute (n=6) and 7‐minute (n=5) ACA experiments during CA, H, and EH (*P*\>0.05). During LH, 7‐minute ACA experiments have significantly greater pulsatility than 5‐minute experiments (*P*=0.03). Experimental phases are baseline (B), CA, H, EH, and LH. (\**P*\<0.05).](JAH3-9-e012691-g004){#jah34707-fig-0004}

CVR Is Correlated to CBF Pulsatility, But Not ABP Pulsatility {#jah34707-sec-0023}
-------------------------------------------------------------

Figure [5](#jah34707-fig-0005){ref-type="fig"}A illustrates a representative experimental rCVR time course. Analyses for rCVR pooled 5‐ and 7‐minute ACA (n=11). Figure [5](#jah34707-fig-0005){ref-type="fig"}B demonstrates that rCVR increases significantly during CA (*P*\<0.001), early hypoperfusion (*P*=0.002), and late hypoperfusion (*P*\<0.001) in comparison to baseline rCVR (n=11). However, rCVR during hyperemia remains similar to baseline rCVR. Interestingly, there was a significant negative correlation between CBF pulsatility and rCVR during hyperemia (*R*=−0.68; *P*=0.025) and late hypoperfusion (*R*=−0.78; *P*=0.007). There was also a modest trend (nonsignificant) toward a negative correlation between CBF pulsatility and rCVR, during early hypoperfusion (*R*=−0.42; *P*=0.20). In contrast, there was no significant correlation between ABP pulsatility and rCVR during hyperemia (*R*=0.04; *P*=0.92), early hypoperfusion (*R*=0.34; *P*=0.31), and late hypoperfusion (*R*=0.16; *P*=0.63). Interestingly, when rCVR and overall CBF were compared, there was no significant association during hyperemia (*R*=−0.52; *P*=0.107), early hypoperfusion (*R*=−0.35; *P*=0.286), and late hypoperfusion (*R*=−0.58; *P*=0.066) (Figure [S2](#jah34707-sup-0001){ref-type="supplementary-material"}). Nevertheless, there was a trend toward significance during late hypoperfusion.

![Relative cerebrovascular resistance (rCVR) increases after resuscitation and is inversely correlated to cerebral blood flow (CBF) pulsatility but not arterial blood pressure (ABP) pulsatility. **A**, Representative experiment illustrating temporal changes in rCVR. **B**, Combined 5‐ and 7‐minute asphyxial cardiac arrest (ACA) shows rCVR is significantly elevated during cardiac arrest (CA) (*P*\<0.001), early hypoperfusion (EH) (*P*=0.002), and late hypoperfusion (LH) (*P*\<0.001), whereas rCVR remains at near baseline (B) levels during hyperemia (H) (*P*=0.17) (n=11). Experimental phases are B, CA, H, EH, and LH. **C** through **E**, Combined 5‐ and 7‐minute ACA comparison of CBF normalized peak‐to‐trough data and rCVR during H, EH, and LH (n=11). **C**, Comparison of CBF pulsatility and normalized rCVR during H (*R*=−0.68; *P*=0.025). **D**, Comparison of CBF pulsatility and normalized rCVR during EH (*R*=−0.42; *P*=0.20). **E**, Comparison of CBF pulsatility and normalized rCVR during LH (*R*=−0.78; *P*=0.007). **F** through **H**, Combined 5‐ and 7‐minute ACA comparison of ABP normalized peak‐to‐trough data and normalized rCVR during H, EH, and LH (n=11). **F**, Comparison of ABP pulsatility and normalized rCVR during H (*R*=0.04; *P*=0.92). **G**, Comparison of ABP pulsatility and normalized rCVR during EH (*R*=0.34; *P*=0.31). **H**, Comparison of ABP pulsatility and normalized rCVR during LH (*R*=0.16; *P*=0.63). (\**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001).](JAH3-9-e012691-g005){#jah34707-fig-0005}

Higher ABP Pulsatility, But Not CBF Pulsatility, Is Associated With Worse Short‐Term Neuroelectrical Recovery {#jah34707-sec-0024}
-------------------------------------------------------------------------------------------------------------

Figure [6](#jah34707-fig-0006){ref-type="fig"}A illustrates a representative experimental EEG IQ time course. We first analyzed whether overall CBF and MAP were correlated to short‐term neuroelectrical recovery (data not shown). Because of excessive bleeding that corrupted EEG signal acquisition, data from one subject were removed from further consideration. Analyses pooled 5‐ and 7‐minute ACA (n=10). There was no significant correlation between overall MAP and EEG IQ 90 minutes after ROSC (a surrogate for short‐term neurological recovery)[31](#jah34707-bib-0031){ref-type="ref"} during hyperemia (*R*=−0.53; *P*=0.12), early hypoperfusion (*R*=−0.31; *P*=0.39), or late hypoperfusion (*R*=−0.32; *P*=0.37). Similarly, there was no significant correlation between overall CBF and EEG IQ 90 minutes after ROSC during hyperemia (*R*=−0.2; *P*=0.58), early hypoperfusion (*R*=−0.21; *P*=0.56), or late hypoperfusion (*R*=−0.13; *P*=0.73).

![Worse short‐term neuroelectrical recovery is associated with higher arterial blood pressure (ABP) pulsatility, whereas changes in cerebral blood flow (CBF) pulsatility are not associated with short‐term neuroelectrical recovery. **A**, Representative experiment that shows temporal changes in electroencephalographic (EEG) information quantity (IQ). **B** through **D**, Combined 5‐ and 7‐minute asphyxial cardiac arrest (ACA) comparisons of CBF normalized peak‐to‐trough data during hyperemia (H), early hypoperfusion (EH), and late hypoperfusion (LH) to EEG IQ 90 minutes after return of spontaneous circulation (ROSC) (n=10). Experimental phases are baseline, cardiac arrest, H, EH, and LH. **B**, Comparison of CBF pulsatility during H and EEG IQ 90 minutes after ROSC (*R*=−0.20; *P*=0.58). **C**, Comparison of CBF pulsatility during EH and EEG IQ 90 minutes after ROSC (*R*=0.21; *P*=0.56). **D**, Comparison of CBF pulsatility during LH and EEG IQ 90 minutes after ROSC (*R*=0.13; *P*=0.73). **E** through **G**, Combined 5‐ and 7‐minute ACA comparisons of ABP normalized peak‐to‐trough data during H, EH, and LH to EEG IQ 90 minutes after ROSC (n=10). **E**, Comparison of ABP pulsatility during H and EEG IQ 90 minutes after ROSC (*R*=−0.32; *P*=0.37). **F**, Comparison of ABP pulsatility during EH and EEG IQ 90 minutes after ROSC (*R*=−0.52; *P*=0.13). **G**, Comparison of ABP pulsatility during LH and EEG IQ 90 minutes after ROSC (*R*=−0.76; *P*=0.016).](JAH3-9-e012691-g006){#jah34707-fig-0006}

We then investigated the relationship between pulsatility metrics and EEG IQ 90 minutes after ROSC. As seen in Figure [6](#jah34707-fig-0006){ref-type="fig"}B through [6](#jah34707-fig-0006){ref-type="fig"}D, there was no significant trend between EEG IQ 90 minutes after ROSC and CBF peak to trough during hyperemia (*R*=−0.20; *P*=0.58), early hypoperfusion (*R*=0.21; *P*=0.56), and late hypoperfusion (*R*=0.13; *P*=0.73). There was no significant trend between EEG IQ 90 minutes after ROSC and ABP peak to trough during hyperemia (*R*=−0.32; *P*=0.37) (Figure 6E) and early hypoperfusion (*R*=−0.52; *P*=0.13) (Figure 6F). However, there was a significant negative trend comparing EEG IQ 90 minutes after ROSC and ABP peak to trough during late hypoperfusion (*R*=−0.76; *P*=0.016) (Figure [6](#jah34707-fig-0006){ref-type="fig"}G).

Discussion {#jah34707-sec-0025}
==========

Pulsatile blood flow is critical in oxygen uptake, vascular tone, cellular metabolism,[3](#jah34707-bib-0003){ref-type="ref"} and the clearance of metabolites through the glymphatics.[33](#jah34707-bib-0033){ref-type="ref"} However, measuring pulsatility remains challenging, especially in the brain. Transcranial Doppler approaches probe the middle cerebral artery and measure CBF pulsatility in humans, but lack information about the cerebral microvasculature, which plays a vital role in oxygen metabolism.[34](#jah34707-bib-0034){ref-type="ref"} Another essential mechanism for brain function, health, and homeostasis is cerebral autoregulation, which is the ability of the brain to maintain CBF when peripheral blood pressure changes. One way to assess cerebral autoregulation is measuring CVR. Simultaneously measuring CBF pulsatility, ABP pulsatility, and CVR has been challenging because of a lack of multimodal platforms. These measurements have been equally difficult in preclinical models because of a lack of high‐speed tools that are needed for the increased heart rate in animal models. However, these measurements in a controlled, preclinical setting are essential to understand the complex physiological characteristics in brain disease and trauma, which drive the need for the development and use of high‐speed tools.

One area of interest where there is a critical need to measure high‐speed changes is CA and resuscitation. We previously published on the relationship between overall CBF and ABP, and how we can use this information to predict the resumption of EEG activity after resuscitation.[18](#jah34707-bib-0018){ref-type="ref"} In this study, we improved on our platform to show, for the first time, simultaneous measurement of CBF pulsatility, ABP pulsatility, and CVR and relate these changes to short‐term neuroelectrical recovery in a preclinical model of CA and resuscitation. Our results reveal that the response of CBF and ABP pulsatility to ACA and resuscitation differs (Figures [3](#jah34707-fig-0003){ref-type="fig"} and [4](#jah34707-fig-0004){ref-type="fig"}); and that CBF pulsatility demonstrates persistent deficits concomitant with increases in rCVR (Figure [5](#jah34707-fig-0005){ref-type="fig"}) that appear independent of overall CBF changes (Figures [S1](#jah34707-sup-0001){ref-type="supplementary-material"} and [S2](#jah34707-sup-0001){ref-type="supplementary-material"}) within 2 hours after resuscitation. Interestingly, these deficits in CBF pulsatility do not appear to be associated with short‐term neuroelectrical recovery, whereas higher ABP pulsatility is associated with worse short‐term neuroelectrical recovery (Figure [6](#jah34707-fig-0006){ref-type="fig"}).

Poor neurological recovery remains a common occurrence for patients with acute brain injury. CA[35](#jah34707-bib-0035){ref-type="ref"}, [36](#jah34707-bib-0036){ref-type="ref"}, [37](#jah34707-bib-0037){ref-type="ref"} and non‐CA[14](#jah34707-bib-0014){ref-type="ref"}, [38](#jah34707-bib-0038){ref-type="ref"}, [39](#jah34707-bib-0039){ref-type="ref"}, [40](#jah34707-bib-0040){ref-type="ref"} studies have quantified CBF and ABP pulsatility attributable to each heartbeat. On the basis of the collective published results, controversy exists about whether higher or lower pulsatility is related to better neurological outcome. For example, the following results from CA studies that examined the middle cerebral artery have reported the following: (1) lower pulsatility index (PI) is associated with good outcome,[37](#jah34707-bib-0037){ref-type="ref"} (2) there is no relationship between PI and survivability up to 72 hours after admission to the intensive care unit,[36](#jah34707-bib-0036){ref-type="ref"} and (3) good neurological outcome had higher PIs in the initial 48 hours after admission to the intensive care unit.[35](#jah34707-bib-0035){ref-type="ref"} Results by van den Brule et al[15](#jah34707-bib-0015){ref-type="ref"} and Lemiale et al[36](#jah34707-bib-0036){ref-type="ref"} suggest that post‐ROSC changes in pulsatile CBF are caused by increased level of vasoconstrictors and cerebral arterial resistance, but that mortality depends on the presence of luxury perfusion. However, these 2 CA studies do not comment on how CBF pulsatility impacts neurological outcome. Non‐CA studies showed that patients with higher pulse pressure, which is analogous to ABP peak to trough measured in this study, have the following: (1) increased likelihood to develop restenosis after percutaneous transluminal coronary angioplasty,[38](#jah34707-bib-0038){ref-type="ref"} (2) higher prevalence of subcortical infarcts and worse cognitive function in the aging population,[39](#jah34707-bib-0039){ref-type="ref"} (3) more severe forms of leukoaraiosis,[14](#jah34707-bib-0014){ref-type="ref"} and (4) higher incidence of stroke.[40](#jah34707-bib-0040){ref-type="ref"} Mitchell et al[39](#jah34707-bib-0039){ref-type="ref"} and Webb et al[14](#jah34707-bib-0014){ref-type="ref"} reported that increased stiffening of the aorta is associated with reduced wave reflection and, therefore, transmission of excessive pulsatility into the brain, which can lead to structural brain damage of the microvasculature and impaired cognitive function.[14](#jah34707-bib-0014){ref-type="ref"}, [39](#jah34707-bib-0039){ref-type="ref"} Our data support this result, as we showed that higher ABP pulsatility is associated with worse short‐term neuroelectrical recovery (Figure [6](#jah34707-fig-0006){ref-type="fig"}G). A key difference is that the findings in previous studies were caused by long‐term increases in pulsatility, which may lead to cerebral microvascular damage. The results presented in our study are related to short‐term changes in ABP pulsatility that occur over the course of \<2 hours after global cerebral ischemia.

One potential reason that short‐term changes in increased ABP pulsatility may lead to more cerebral microvascular damage is impaired cerebral autoregulation. After CA, cerebral autoregulation is impaired[41](#jah34707-bib-0041){ref-type="ref"}, [42](#jah34707-bib-0042){ref-type="ref"} and overall CBF diminished, but ABP recovers to baseline levels.[18](#jah34707-bib-0018){ref-type="ref"}, [32](#jah34707-bib-0032){ref-type="ref"}, [43](#jah34707-bib-0043){ref-type="ref"}, [44](#jah34707-bib-0044){ref-type="ref"} Several studies reported that higher variability in low‐frequency CBF and MAP signals 72 hours after admission to the intensive care unit was associated with increased chance of survival.[17](#jah34707-bib-0017){ref-type="ref"} These studies suggested that decreased low‐frequency variability and higher mortality are associated with impaired myogenic response and autonomic regulation.[17](#jah34707-bib-0017){ref-type="ref"} However, previous studies did not compare cerebral autoregulation measures, such as CVR, to CBF and ABP pulsatility. Our imaging approach provides the requisite capabilities to monitor these hyperdynamic changes in relation to short‐term neuroelectrical recovery. Our data suggest that CVR is elevated during the hypoperfusion phases after resuscitation (Figure [5](#jah34707-fig-0005){ref-type="fig"}B), and is associated with CBF pulsatility but not ABP pulsatility (Figure [5](#jah34707-fig-0005){ref-type="fig"}C through [5](#jah34707-fig-0005){ref-type="fig"}H). These results suggest that CVR may be more dependent on pulsatile cerebral hemodynamics than pulsatile peripheral hemodynamics. However, in cases of impaired cerebral autoregulation, excessive peripheral pulsatility and overall hemodynamics may lead to damage of cerebral microvasculature. We did not observe a significant difference between CVR for 5‐ and 7‐minute ACA experiments during any of the time points (*P*\>0.05). However, during late hypoperfusion, subjects experiencing 7‐minute ACA had significantly more ABP pulsatility than those experiencing 5‐minute ACA (*P*=0.03). Thus, we postulate that more severe CA affects cerebral autoregulation and increases ABP pulsatility. Hence, the brain is unable to modulate the increased ABP pulsatility, which may lead to increased reperfusion‐mediated cerebral microvascular damage. On the basis of the demonstrated association between CVR and CBF pulsatility (Figure [5](#jah34707-fig-0005){ref-type="fig"}C through [5](#jah34707-fig-0005){ref-type="fig"}E), we hypothesize that a normal CVR, or less impaired cerebral autoregulation, enables the brain to minimize the potential harm that an elevated pulsatile ABP may cause the cerebral microvasculature, which in turn may lead to better neurological recovery.

However, another potential explanation of the association between higher ABP pulsatility and worse short‐term neuroelectrical recovery could be that the subjects with higher ABP pulsatility experienced more severe ACA (Figure [4](#jah34707-fig-0004){ref-type="fig"}). The more severe ACA and increase in ABP pulsatility may lead not only to more damage to the cerebral microvasculature, but also to the cardiac and systemic microvasculature. Furthermore, the increase in ABP pulsatility may also be a compensatory mechanism after more severe global ischemia to potentially offset the observed deficits in CBF pulsatility (Figure [3](#jah34707-fig-0003){ref-type="fig"}). To address these gaps, mechanistic studies are needed to determine causality between severity of ACA, CBF pulsatility, and ABP pulsatility and how these affect the brain and neurological outcome. A better understanding of how cerebral, cardiac, and systemic vasculature is affected after CA pulsatility may also help target future development and use of therapeutic agents after CA.

Hemodynamic targets for patients experiencing CA rely on targeting systolic blood pressure and MAP of \>90 and 65 mm Hg, respectively.[45](#jah34707-bib-0045){ref-type="ref"} These targets typically do not consider ABP pulsatility. Studies have shown that exceeding a threshold of MAP is associated with good neurological recovery[46](#jah34707-bib-0046){ref-type="ref"}, [47](#jah34707-bib-0047){ref-type="ref"}; however, these studies did not examine the relationship between pulse pressure and elevated MAP on neurological outcome. Our results, which show that higher ABP pulsatility is associated with worse short‐term neuroelectrical recovery parameters, suggest that monitoring acute ABP pulsatility may help inform neurological recovery after CA. We postulate that a combined effort to monitor MAP and pulse pressure could potentially lead to discoveries that can allow for minimization of cerebral microvascular damage and possibly improve good neurological outcome after CA. Epinephrine administration is the standard of clinical practice during cardiopulmonary resuscitation.[48](#jah34707-bib-0048){ref-type="ref"} However, recent studies demonstrated that epinephrine alone can lead to decreased survivability and worse neurological outcome than when epinephrine is combined with vasopressin or sodium nitroprusside.[49](#jah34707-bib-0049){ref-type="ref"}, [50](#jah34707-bib-0050){ref-type="ref"}, [51](#jah34707-bib-0051){ref-type="ref"}, [52](#jah34707-bib-0052){ref-type="ref"}, [53](#jah34707-bib-0053){ref-type="ref"}, [54](#jah34707-bib-0054){ref-type="ref"} It is not clear how these drugs affect pulsatility of the peripheral arteries versus cerebral arteries. Future studies that determine how these drugs affect pulsatility, and therapeutic modulation of pulsatility during the short‐term period after CA (within 2 hours), may be critical to achieving an overall improvement in neurological outcome.

Limitations {#jah34707-sec-0026}
-----------

Although the findings of this study warrant further investigations, there are several limitations. First, global regions of interest within the craniectomy were chosen to calculate CBF data, and therefore we did not distinguish between arteriolar and venular pulsatility, which has recently been shown with LSI.[25](#jah34707-bib-0025){ref-type="ref"} In separate analyses of our data, regions of interest that were taken exclusively from arterioles were analyzed. Our data resulted in poor signal/noise ratio of the pulsatile waveform, which did not enable the use of the quantifiable metrics presented in this study. Furthermore, another limitation of using LSI to quantify pulsatility is that it cannot calculate PI, a well‐accepted measure of pulsatility. Absolute velocity is needed to calculate PI; however, the LSI signal is more of a perfusion measurement. Also, although the data analyses presented herein produce statistical significance and trends, the power of these findings is limited because of the small sample size and complexity of experiments. Specifically, there appears to be a trend toward decreased CBF pulsatility and longer duration of ACA, but we did not see statistically significant differences (Figure [4](#jah34707-fig-0004){ref-type="fig"}A and [4](#jah34707-fig-0004){ref-type="fig"}B). Furthermore, these experiments used a craniectomy, which may affect pulsatile CBF changes because of differences in intracranial pressure and brain pulsations. A chronic cranial window may mitigate such effects. To address this limitation, we performed 2 ACA experiments using a chronic cranial window procedure[55](#jah34707-bib-0055){ref-type="ref"} that showed similar changes in CBF pulsatility compared with the open craniectomy procedure (Figure [S3](#jah34707-sup-0001){ref-type="supplementary-material"}). Moreover, we used isoflurane to induce anesthesia, which may impact CBF and ABP pulsatility. Isoflurane was turned off 3 minutes before onset of asphyxia to minimize isoflurane effects on pulsatility. In addition, the correlations in this study combined the 5‐ and 7‐minute ACA groups because of the small sample size. Moreover, because we used young, healthy animals, these data should be reinvestigated in aged animals with heart disease and decreased cardiac function to better mimic the human population at highest risk of CA. It may be possible that ABP pulsatility and compensatory cardiac function after CA are highly different in the diseased state. Thus, future work should use larger sample sizes in varying severities of ACA using young and aged animals and use linear regression models. Our metric of neurological outcome (EEG IQ), although it is an objective end point that has been previously validated,[31](#jah34707-bib-0031){ref-type="ref"} is not based on cognitive,[56](#jah34707-bib-0056){ref-type="ref"} behavioral,[21](#jah34707-bib-0021){ref-type="ref"} or histopathological outcomes.[37](#jah34707-bib-0037){ref-type="ref"}, [57](#jah34707-bib-0057){ref-type="ref"} Finally, the results in this study only measured acute pulsatility changes. Use of a wearable imaging device[27](#jah34707-bib-0027){ref-type="ref"}, [55](#jah34707-bib-0055){ref-type="ref"}, [58](#jah34707-bib-0058){ref-type="ref"} over a chronic cranial window will enable longer‐term monitoring of CBF pulsatility.

Conclusions {#jah34707-sec-0027}
===========

We used our translational preclinical model of ACA and a multimodal measurement platform to demonstrate that CBF pulsatility dynamically changes after resuscitation, whereas ABP pulsatility changes little. rCVR appears to be associated to changes in CBF pulsatility, but not ABP pulsatility. We found that our observed changes in CBF pulsatility are not correlated with short‐term neuroelectrical recovery, whereas higher ABP pulsatility is associated with worse short‐term neuroelectrical recovery. We postulate that impaired cerebral autoregulation after CA may contribute to higher ABP pulsatility, leading to worse short‐term neuroelectrical recovery. However, this may also be attributable to higher ABP pulsatility being associated with more severe ACA. Clinical translation of these findings has the potential to inform us on the development of novel interventions that modulate cerebral autoregulation and ABP pulsatility within the first 2 hours after ROSC, which could potentially improve neurological outcome for CA survivors.
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**Data S1.** Relationship among cerebral blood flow pulsatility, cerebrovascular resistance, and overall cerebral blood flow, during various stages of cardiac arrest and resuscitation.

**Figure S1.** Cerebral blood flow (CBF) pulsatility and overall CBF are associated during hyperemia, but not early and late hypoperfusion.

**Figure S2.** Overall cerebral blood flow (CBF) and relative cerebrovascular resistance (rCVR) are not significantly associated post‐cardiac arrest (CA).

**Figure S3.** Chronic cranial window cerebral blood flow (CBF) pulsatility agrees with open craniectomy CBF pulsatility.

###### 

Click here for additional data file.
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